...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
【24h】

Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.

机译:血小板活化因子在嗜酸性粒细胞跨肺上皮细胞单层迁移中的三重作用:嗜酸性粒细胞趋化剂和引发剂以及上皮细胞活化剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Infiltration of eosinophils into the lung lumen is a hallmark of allergic asthmatic inflammation. To reach the lung lumen, eosinophils must migrate across the vascular endothelium, through the interstitial matrix, and across the lung epithelium. The regulation of this process is obscure. In this study, we investigated the migration of human eosinophils across confluent monolayers of either human lung H292 epithelial cells or primary human bronchial epithelial cells. Established eosinophil chemoattractants (IL-8, RANTES, platelet-activating factor (PAF), leukotriene B4, and complement fragment 5a (C5a)) or activation of the epithelial cells with IL-1beta induced little eosinophil transmigration (<7% in 2 h). In contrast, addition of PAF in combination with C5a induced extensive (>20%) transepithelial migration of unprimed and IL-5-primed eosinophils. Eosinophil migration assessed in a Boyden chamber assay, i.e., without an epithelial monolayer, was only slightly increased upon addition of PAF and C5a. Preincubation of eosinophils with the PAF receptor antagonist WEB 2086 only inhibited migration of unprimed eosinophils toward PAF and C5a, whereas preincubation of epithelial cells with WEB 2086 abolished migration of both IL-5-primed and unprimed eosinophils. This latter result indicated the presence of PAF receptors on epithelial cells. Indeed, addition of PAF to epithelial cells induced an increase in cytosolic free Ca2+, which was blocked by the PAF receptor antagonists WEB 2086 and TCV-309. Our results show that PAF induces permissive changes in epithelial cells, and that PAF acts as a chemoattractant and priming agent for the eosinophils.
机译:嗜酸性粒细胞浸入肺腔是过敏性哮喘炎症的标志。为了到达肺腔,嗜酸性粒细胞必须迁移穿过血管内皮,穿过间质基质并穿过肺上皮。这个过程的调节是模糊的。在这项研究中,我们调查了人类嗜酸性粒细胞跨人H292上皮细胞或原代人支气管上皮细胞汇合单层的迁移。已建立的嗜酸性粒细胞趋化因子(IL-8,RANTES,血小板活化因子(PAF),白三烯B4和补体片段5a(C5a))或用IL-1β活化的上皮细胞几乎不会引起嗜酸性粒细胞迁移(在2小时内<7%) )。相比之下,PAF与C5a的结合会诱导未引发的和IL-5引发的嗜酸性粒细胞广泛(> 20%)跨上皮迁移。在Boyden室测定法中评估的嗜酸性粒细胞迁移,即,没有上皮单层,在添加PAF和C5a时仅稍微增加。嗜酸性粒细胞与PAF受体拮抗剂WEB 2086的预温育仅抑制未引发的嗜酸性粒细胞向PAF和C5a的迁移,而上皮细胞与WEB 2086的预温育则消除了IL-5引发和未引发的嗜酸性粒细胞的迁移。后一结果表明上皮细胞上存在PAF受体。确实,在上皮细胞中添加PAF会诱导胞质游离Ca2 +的增加,这被PAF受体拮抗剂WEB 2086和TCV-309阻止。我们的结果表明,PAF诱导了上皮细胞的允许变化,并且PAF充当了嗜酸性粒细胞的趋化剂和引发剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号